Rigel Pharmaceuticals (RIGL) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	25.95M
Available-for-sale securities
Prepaid expenses and other current assets	1.29M
Total current assets	86.55M
Property and equipment, net	1.29M
Other assets	800K
Total assets	88.64M
Accounts payable	1.52M
Accrued compensation	4.55M
Other accrued liabilities	1.04M
Deferred revenue	0
Capital lease obligations
Total current liabilities	20.63M
Long-term portion of capital lease obligations
Long-term portion of deferred rent	994K
Other long-term liabilities	8K
Commitments and contingencies	0
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding as of June 30, 2011 and December 31, 2010	0
Common stock, $0.001 par value; 100,000,000 shares authorized; 71,203,011 and 52,271,184 shares issued and outstanding as of June 30, 2011 and December 31, 2010, respectively	99K
Additional paid-in capital	1.11B
Accumulated other comprehensive income (loss)	9K
Accumulated deficit	-1.05B
Total stockholders' equity
Total liabilities and stockholders' equity	88.64M

Entities mentioned with RIGL

View All Entities